27.1.2017   

IT

Gazzetta ufficiale dell’Unione europea

C 28/1


Sintesi delle decisioni dell’Unione europea relative alle autorizzazioni all’immissione in commercio di medicinali dal 1o dicembre 2016 al 31 dicembre 2016

[pubblicate a norma dell’articolo 13 o dell’articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio (1)]

(2017/C 028/01)

* * *

—

Rilascio di un’autorizzazione all’immissione in commercio [articolo 13 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio]: Accettate

Data della decisione

Denominazione del medicinale

DCI (denominazione comune internazionale)

Titolare dell’autorizzazione all’immissione in commercio

Numero d’iscrizione nel registro comunitario

Forma farmaceutica

Codice ATC (anatomico, terapeutico e chimico)

Data di notifica

5.12.2016

Venclyxto

venetoclax

AbbVie Ltd

Vanwall Road, Maidenhead, SL6 4UB, United Kingdom

EU/1/16/1138

Compressa rivestita con film

L01X

7.12.2016

8.12.2016

Emtricitabine/Tenofovir disoproxil Krka

emtricitabina/tenofovir disoproxil

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/16/1151

Compressa rivestita con film

J05AR03

12.12.2016

8.12.2016

SomaKit TOC

edotreotide

Advanced Accelerator Applications

20 rue Diesel, F-1630 Saint-Genis-Pouilly, France

EU/1/16/1141

Polvere per soluzione iniettabile

V09IX09

12.12.2016

8.12.2016

Tenofovir disoproxil Mylan

Tenofovir disoproxil

MYLAN S.A.S

117 Allée des Parcs, 69800 Saint-Priest, France

EU/1/16/1129

Compressa rivestita con film

J05AF07

12.12.2016

12.12.2016

OCALIVA

acido obeticolico

Intercept Pharma Ltd

2 Pancras Square, London N1C 4AG, United Kingdom

EU/1/16/1139

Compressa rivestita con film

A05AA04

15.12.2016

12.12.2016

Rekovelle

follitropina delta

Ferring Pharmaceuticals A/S

Kay Fiskers Plads 11, DK-2300 Copenhagen S, Danmark

EU/1/16/1150

 

G03GA10

14.12.2016

16.12.2016

Emtricitabine/Tenofovir disoproxil Mylan

emtricitabina/tenofovir disoproxil

Mylan S.A.S

117 allée des Parcs, F-69800 Saint Priest, France

EU/1/16/1133

Compressa rivestita con film

J05AR03

20.12.2016

—

Modifica di un’autorizzazione all’immissione in commercio [articolo 13 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio]: Accettate

Data della decisione

Denominazione del medicinale

Titolare dell’autorizzazione all’immissione in commercio

Numero d’iscrizione nel registro comunitario

Data di notifica

2.12.2016

Aclasta

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/05/308

6.12.2016

5.12.2016

Pioglitazone Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/11/722

7.12.2016

5.12.2016

Spedra

Menarini International Operations Luxembourg S.A.

1 avenue de la Gare, L-1611 Luxembourg, Grand-Duché de Luxembourg

EU/1/13/841

7.12.2016

5.12.2016

Truberzi

Allergan Pharmaceuticals International Limited

Clonshaugh Industrial Estate, Coolock, Dublin 17, Ireland

EU/1/16/1126

7.12.2016

8.12.2016

Acido zoledronico Actavis

Actavis Group PTC ehf.

Reykjavíkurvegi 76-78, 220 Hafnarfjörður, Íceland

EU/1/12/759

12.12.2016

8.12.2016

Actraphane

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/229

12.12.2016

8.12.2016

Actrapid

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/230

12.12.2016

8.12.2016

Adenuric

Menarini International Operations Luxembourg S.A.

1 avenue de la Gare, L-1611 Luxembourg, Grand-Duché de Luxembourg

EU/1/08/447

12.12.2016

8.12.2016

Bosulif

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/13/818

12.12.2016

8.12.2016

CONTROLOC Control

Takeda GmbH, (HRB 701016)

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/09/515

12.12.2016

8.12.2016

Cystadane

Orphan Europe S.A.R.L.

Immeuble Le Wilson, 70 avenue du Général de Gaulle, F-92 800 Puteaux, France

EU/1/06/379

12.12.2016

8.12.2016

DuoPlavin

Sanofi Clir Snc

54 rue La Boétie, F-75008 Paris, France

EU/1/10/619

12.12.2016

8.12.2016

Eperzan

GlaxoSmithKline Trading Services Limited

Currabinny, Carrigaline, County Cork, Ireland

EU/1/13/908

14.12.2016

8.12.2016

GILENYA

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/11/677

12.12.2016

8.12.2016

Holoclar

Chiesi Farmaceutici S.P.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/14/987

12.12.2016

8.12.2016

Icandra

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/08/484

12.12.2016

8.12.2016

Lamivudine/Zidovudine Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/10/663

12.12.2016

8.12.2016

Mimpara

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/04/292

5.12.2016

8.12.2016

Otezla

Celgene Europe Limited

1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

EU/1/14/981

12.12.2016

8.12.2016

PANTOZOL Control

Takeda GmbH, (HRB 701016)

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/09/517

12.12.2016

8.12.2016

SOMAC Control

Takeda GmbH, (HRB 701016)

Byk-Gulden-Str. 2, D-78467 Konstanz, Deutschland

EU/1/09/516

12.12.2016

8.12.2016

Voriconazolo Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/13/835

12.12.2016

8.12.2016

Zebinix

Bial — Portela & Ca, SA

À Av. da Siderurgia Nacional 4745-457 S. Mamede do Coronado, Portugal

EU/1/09/514

12.12.2016

9.12.2016

Ecansya

Krka, d. d., Novo Mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/12/763

12.12.2016

12.12.2016

Accofil

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/14/946

14.12.2016

12.12.2016

Aldara

Meda AB

Pipers väg 2 A, SE-170 73 Solna, Sverige

EU/1/98/080

14.12.2016

12.12.2016

Aripiprazole Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/15/1045

14.12.2016

12.12.2016

Colobreathe

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/11/747

14.12.2016

12.12.2016

Cometriq

Ipsen Pharma

65 quai Georges Gorse, F-92100 Boulogne-Billancourt, France

EU/1/13/890

14.12.2016

12.12.2016

Competact

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/06/354

14.12.2016

12.12.2016

Crixivan

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/96/024

14.12.2016

12.12.2016

Docetaxel Kabi

Fresenius Kabi Oncology Plc.

Lion Court, Farnham Road, Bordon, Hampshire GU35 0NF, United Kingdom

EU/1/12/770

15.12.2016

12.12.2016

Ebymect

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/15/1051

14.12.2016

12.12.2016

Efficib

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/457

14.12.2016

12.12.2016

Eucreas

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/425

14.12.2016

12.12.2016

Flebogamma DIF

Instituto Grifols, S.A.

Can Guasch 2, Parets del Vallès, E-08150 Barcelona, Espaňa

EU/1/07/404

14.12.2016

12.12.2016

Glubrava

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/07/421

14.12.2016

12.12.2016

Humira

AbbVie Ltd

Maidenhead, SL6 4UB, United Kingdom

EU/1/03/256

14.12.2016

12.12.2016

Inflectra

Hospira UK Limited

Horizon, Honey Lane, Hurley, Maidenhead, SL6 6RJ, United Kingdom

EU/1/13/854

14.12.2016

12.12.2016

Janumet

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/455

14.12.2016

12.12.2016

Jentadueto

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/12/780

14.12.2016

12.12.2016

Komboglyze

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/11/731

14.12.2016

12.12.2016

Kyprolis

Amgen Europe B.V.

Minervum 7061, NL-4817 ZK Breda, Nederland

EU/1/15/1060

14.12.2016

12.12.2016

Lynparza

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/14/959

14.12.2016

12.12.2016

Mysimba

Orexigen Therapeutics Ireland Limited

2nd Floor, Palmerston House, Fenian Street, Dublin 2, Ireland

EU/1/14/988

14.12.2016

12.12.2016

Nimenrix

Pfizer Limited

Ramsgate Road, Sandwich, Kent CT13 9NJ, United Kingdom

EU/1/12/767

14.12.2016

12.12.2016

NovoMix

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/00/142

14.12.2016

12.12.2016

Optaflu

Seqirus GmbH

Emil-von-Behring-Strasse 76, 35041 Marburg, Deutschland

EU/1/07/394

14.12.2016

12.12.2016

Orbactiv

The Medicines Company UK Ltd

115L Milton Park, Abingdon, Oxfordshire OX14 4SA, United Kingdom

EU/1/15/989

14.12.2016

12.12.2016

Pregabalin Accord

Accord Healthcare Limited

Sage House, 319 Pinner Road, North Harrow, Middlesex, HA1 4HF, United Kingdom

EU/1/15/1027

14.12.2016

12.12.2016

Ristfor

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/10/620

14.12.2016

12.12.2016

Synjardy

Boehringer Ingelheim International GmbH

Binger Straße 173, D-55216 Ingelheim am Rhein, Deutschland

EU/1/15/1003

14.12.2016

12.12.2016

TAGRISSO

AstraZeneca AB

Gärtunavägen, SE-151 85 Södertälje, Sverige

EU/1/16/1086

14.12.2016

12.12.2016

Trulicity

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/14/956

14.12.2016

12.12.2016

Velmetia

Merck Sharp & Dohme Limited

Hertford Road, Hoddesdon, Hertfordshire EN11 9BU, United Kingdom

EU/1/08/456

14.12.2016

12.12.2016

Vimpat

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/08/470

14.12.2016

12.12.2016

Vipdomet

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/13/843

14.12.2016

12.12.2016

Vokanamet

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/14/918

14.12.2016

12.12.2016

Xigduo

AstraZeneca AB

SE-151 85 Södertälje, Sverige

EU/1/13/900

14.12.2016

12.12.2016

Xtandi

Astellas Pharma Europe B.V.

Sylviusweg 62, NL-2333 BE Leiden, Nederland

EU/1/13/846

14.12.2016

12.12.2016

Zomarist

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/08/483

14.12.2016

13.12.2016

GONAL-f

Merck Serono Europe Limited

56, Marsh Wall, London E14 9TP, United Kingdom

EU/1/95/001

16.12.2016

16.12.2016

Atripla

Bristol-Myers Squibb and Gilead Sciences Limited

IDA Business & Technology Park, Carrigtohill, Co. Cork, Ireland

EU/1/07/430

21.12.2016

16.12.2016

Caprelsa

Genzyme Europe B.V.

Gooimeer 10, NL-1411 DD Naarden, Nederland

EU/1/11/749

20.12.2016

16.12.2016

Kentera

Nicobrand Limited

189 Castleroe Road, Coleraine, Northern Ireland BT51 3 RP, United Kindom

EU/1/03/270

20.12.2016

16.12.2016

Levemir

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/04/278

20.12.2016

16.12.2016

Mixtard

Novo Nordisk A/S

Novo Allé, DK-2880 Bagsvaerd, Danmark

EU/1/02/231

20.12.2016

16.12.2016

Pemetrexed Lilly

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/15/1034

20.12.2016

16.12.2016

Pramipexole Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/08/490

20.12.2016

16.12.2016

RotaTeq

Sanofi Pasteur MSD SAS

162 avenue Jean Jaurès, 69007 Lyon, France

EU/1/06/348

20.12.2016

16.12.2016

Sebivo

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/07/388

20.12.2016

19.12.2016

Entyvio

Takeda Pharma A/S

Dybendal Alle 10, 2630 Taastrup, Danmark

EU/1/14/923

21.12.2016

19.12.2016

Pemetrexed Sandoz

Sandoz GmbH

Biochemiestrasse 10, A-6250 Kundl, Österreich

EU/1/15/1037

21.12.2016

19.12.2016

Tractocile

Ferring Pharmaceuticals A/S

Kay Fiskers Plads 11, DK-2300 Copenhagen S, Danmark

EU/1/99/124

21.12.2016

19.12.2016

Visudyne

Novartis Europharm Limited

Frimley Business Park, Camberley GU16 7SR, United Kingdom

EU/1/00/140

21.12.2016

23.12.2016

Duloxetine Mylan

Generics [UK] Limited

Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

EU/1/15/1010

5.1.2017

23.12.2016

Fareston

Orion Corporation

Orionintie 1, FI-02200 Espoo, Suomi

EU/1/96/004

4.1.2017

23.12.2016

Invirase

Roche Registration Limited

6 Falcon Way, Shire Park, Welwyn Garden City, AL7 1TW, United Kingdom

EU/1/96/026

4.1.2017

23.12.2016

Mepact

Takeda France SAS

Immeuble Pacific, 11-13 cours Valmy, 92800 Puteaux, France

EU/1/08/502

4.1.2017

23.12.2016

Orkambi

Vertex Pharmaceuticals (Europe) Limited

2 Kingdom Street, London W2 6BD, United Kingdom

EU/1/15/1059

4.1.2017

23.12.2016

Raplixa

Mallinckrodt Pharmaceuticals Ireland Limited

College Business & Technology Park Cruiserath, Blanchardstown, Dublin 15, Ireland

EU/1/14/985

4.1.2017

23.12.2016

Sirturo

Janssen-Cilag International NV

Turnhoutseweg 30, B-2340 Beerse, België

EU/1/13/901

4.1.2017

—   Ritiro di un’autorizzazione all’immissione in commercio [articolo 13 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio]

Data della decisione

Denominazione del medicinale

Titolare dell’autorizzazione all’immissione in commercio

Numero d’iscrizione nel registro comunitario

Data di notifica

16.12.2016

Budesonide/Formoterol Teva

Teva Pharma B.V.

Swensweg 5, 2031GA Haarlem, Nederland

EU/1/14/948

20.12.2016

16.12.2016

Budesonide/Formoterol Teva Pharma B.V.

Teva Pharma B.V.

Swensweg 5, 2031GA Haarlem, Nederland

EU/1/14/950

20.12.2016

—   Rilascio di un’autorizzazione all’immissione in commercio [articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio]: Accettate

Data della decisione

Denominazione del medicinale

DCI (denominazione comune internazionale)

Titolare dell’autorizzazione all’immissione in commercio

Numero d’iscrizione nel registro comunitario

Forma farmaceutica

Codice ATC (anatomico, terapeutico e chimico)

Data di notifica

13.12.2016

Cepedex

dexmedetomidina

CP Pharma Handelsgesellschaft mbH

Ostlandring 13, D-31303 Burgdorf, Deutschland

EU/2/16/200

Soluzione iniettabile

QN05CM18

15.12.2016

13.12.2016

Halagon

alofuginone

Emdoka bvba

J. Lijsenstraat 16, B-2321 Hoogstraten, België

EU/2/16/201

Soluzione orale

QP51AX08

15.12.2016

—   Modifica di un’autorizzazione all’immissione in commercio [articolo 38 del regolamento (CE) n. 726/2004 del Parlamento europeo e del Consiglio]: Accettate

Data della decisione

Denominazione del medicinale

Titolare dell’autorizzazione all’immissione in commercio

Numero d’iscrizione nel registro comunitario

Data di notifica

13.12.2016

Parvoduk

Merial

29 avenue Tony Garnier, F-69007 Lyon, France

EU/2/14/162

15.12.2016

13.12.2016

Zulvac 1 + 8 Bovis

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/12/139

15.12.2016

14.12.2016

Activyl Tick Plus

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/11/137

16.12.2016

14.12.2016

Porcilis PCV M Hyo

Intervet International B.V.

Wim de Körverstraat 35, NL-5831 AN Boxmeer, Nederland

EU/2/14/175

16.12.2016

14.12.2016

Versican Plus DHPPi

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/169

16.12.2016

14.12.2016

Versican Plus DHPPi/L4

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/164

16.12.2016

14.12.2016

Versican Plus DHPPi/L4R

Zoetis Belgium S.A.

Rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/14/163

16.12.2016

Per consultare la relazione pubblica di valutazione sui medicinali in questione e le correlate decisioni contattare:

European Medicines Agency

30 Churchill Place

Canary Wharf

London E14 5EU

United Kingdom


(1)  GU L 136 del 30.4.2004, pag. 1.